NCT03551912

Brief Summary

The Nigerian Surgical Outcome Study is a national 30-day observational cohort study of complications after surgery. Various institutions across Nigeria will be involved. The study aims at providing detailed data describing post-operative complications, requirement for intensive care and mortality. All patients undergoing either elective surgery during a 7-day study period with a planned overnight stay will be recruited.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

June 1, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 11, 2018

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 12, 2018

Completed
Last Updated

June 11, 2018

Status Verified

June 1, 2018

Enrollment Period

13 days

First QC Date

May 26, 2018

Last Update Submit

June 7, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-operative complications

    In-hospital post-operative complications of any cause

    At discharge or 30 days, whichever is earlier.

Secondary Outcomes (4)

  • Mortality

    Within 24 hours

  • Mortality

    At 30 days after surgery

  • Critical care admission

    At 30 days after surgery

  • Duration of hospital stay

    At discharge or 30 days

Interventions

SurgeryPROCEDURE

All patients coming for elective surgery

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults or Paediatrics coming for elective surgical procedures

You may qualify if:

  • All consecutive patients admitted to participating centres undergoing elective surgery with a planned overnight hospital stay following surgery during a seven-day study period. The recruitment week will run between June and July 2018.

You may not qualify if:

  • Patients undergoing planned day-case surgery or procedures outside the operating theatre.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College Hospital

Ibadan, Oyo State, 2340001, Nigeria

Location

Related Publications (2)

  • Biccard BM, Madiba TE, Kluyts HL, Munlemvo DM, Madzimbamuto FD, Basenero A, Gordon CS, Youssouf C, Rakotoarison SR, Gobin V, Samateh AL, Sani CM, Omigbodun AO, Amanor-Boadu SD, Tumukunde JT, Esterhuizen TM, Manach YL, Forget P, Elkhogia AM, Mehyaoui RM, Zoumeno E, Ndayisaba G, Ndasi H, Ndonga AKN, Ngumi ZWW, Patel UP, Ashebir DZ, Antwi-Kusi AAK, Mbwele B, Sama HD, Elfiky M, Fawzy MA, Pearse RM; African Surgical Outcomes Study (ASOS) investigators. Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study. Lancet. 2018 Apr 21;391(10130):1589-1598. doi: 10.1016/S0140-6736(18)30001-1. Epub 2018 Jan 3.

  • International Surgical Outcomes Study group. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016 Oct 31;117(5):601-609. doi: 10.1093/bja/aew316.

MeSH Terms

Conditions

Postoperative Complications

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Babatunde Babatunde, MBChB,FMCA

    University of Ibadan/University College Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Babatunde Osinaike, MBChB,FMCA

CONTACT

Bolaji Oyedepo, OND

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Reader

Study Record Dates

First Submitted

May 26, 2018

First Posted

June 11, 2018

Study Start

June 1, 2018

Primary Completion

June 14, 2018

Study Completion

August 12, 2018

Last Updated

June 11, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Data will be pseudo-anonymised by generation of a unique numeric code and transcribed by local investigators onto an internet based electronic CRF. Each patient will only be identified on the electronic CRF by their numeric code; thus the co- ordinating study team cannot trace data back to an individual patient without contact with the local team.

Locations